HemaSphere
(Jun 2022)
S133: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
- R. Huang,
- Q. Wen,
- X. Wang,
- H. Yan,
- Y. Ma,
- M. Wang,
- X. Han,
- L. Gao,
- L. Gao,
- C. Zhang,
- X. Zhang
Affiliations
- R. Huang
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- Q. Wen
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- X. Wang
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- H. Yan
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- Y. Ma
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- M. Wang
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- X. Han
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- L. Gao
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- L. Gao
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- C. Zhang
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- X. Zhang
- 1 Medical Center of Hematology, Xinqiao Hospital of Army Medical University,, Chongqing, China
- DOI
-
https://doi.org/10.1097/01.HS9.0000843424.14245.d9
- Journal volume & issue
-
Vol. 6
pp.
34
– 35
WeChat QR code